Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary R Matyas

Showing results (11-20 of 120) with videos related to

Pageof 12
Sort By:
Journal of Visualized Experiments : Jove|September 10, 2019
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope PresentationChristopher P Karch, Peter Burkhard, Gary R Matyas, et al.
Future Virology|March 1, 2019
Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccineChristopher P Karch, Gary R Matyas, Peter Burkhard, et al.
Nanomedicine (London, England)|October 2, 2018
Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine developmentChristopher P Karch, Gary R Matyas, Peter Burkhard, et al.
Expert Opinion on Drug Delivery|February 12, 2016
Liposomal adjuvants for human vaccinesCarl R Alving, Zoltan Beck, Gary R Matyas, et al.
Journal of Drug Targeting|August 8, 2008
Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopesZoltan Beck, Nicos Karasavvas, Gary R Matyas, et al.
Biochimica Et Biophysica Acta|December 23, 2008
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1Gary R Matyas, Zoltan Beck, Nicos Karasavvas, et al.
Journal of Liposome Research|October 24, 2018
Saturated phospholipids are required for nano- to micron-size transformation of cholesterol-containing liposomes upon QS21 additionPushpendra Singh, Zoltan Beck, Gary R Matyas, et al.
Pharmaceutics|September 28, 2023
QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar VesiclesErwin G Abucayon, Mangala Rao, Gary R Matyas, et al.
Pharmaceutics|September 27, 2025
Mechanisms of Self-Assembly of Giant Unilamellar Vesicles in the Army Liposome Formulation (ALF) Family of Vaccine AdjuvantsCalin Nicolescu, Essie Komla, Mangala Rao, et al.
Molecular Membrane Biology|November 28, 2006
HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodiesCarl R Alving, Zoltan Beck, Nicos Karasavva, et al.
Pageof 12

Showing results (11-20 of 120) with videos related to

Sort By:
Pageof 12
Journal of Visualized Experiments : Jove|September 10, 2019
Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope PresentationChristopher P Karch, Peter Burkhard, Gary R Matyas, et al.
Future Virology|March 1, 2019
Glycosylation of the HIV-1 Env V1V2 loop to form a native-like structure may not be essential with a nanoparticle vaccineChristopher P Karch, Gary R Matyas, Peter Burkhard, et al.
Nanomedicine (London, England)|October 2, 2018
Self-Assembling Protein Nanoparticles: implications for HIV-1 vaccine developmentChristopher P Karch, Gary R Matyas, Peter Burkhard, et al.
Expert Opinion on Drug Delivery|February 12, 2016
Liposomal adjuvants for human vaccinesCarl R Alving, Zoltan Beck, Gary R Matyas, et al.
Journal of Drug Targeting|August 8, 2008
Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopesZoltan Beck, Nicos Karasavvas, Gary R Matyas, et al.
Biochimica Et Biophysica Acta|December 23, 2008
Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1Gary R Matyas, Zoltan Beck, Nicos Karasavvas, et al.
Journal of Liposome Research|October 24, 2018
Saturated phospholipids are required for nano- to micron-size transformation of cholesterol-containing liposomes upon QS21 additionPushpendra Singh, Zoltan Beck, Gary R Matyas, et al.
Pharmaceutics|September 28, 2023
QS21-Initiated Fusion of Liposomal Small Unilamellar Vesicles to Form ALFQ Results in Concentration of Most of the Monophosphoryl Lipid A, QS21, and Cholesterol in Giant Unilamellar VesiclesErwin G Abucayon, Mangala Rao, Gary R Matyas, et al.
Pharmaceutics|September 27, 2025
Mechanisms of Self-Assembly of Giant Unilamellar Vesicles in the Army Liposome Formulation (ALF) Family of Vaccine AdjuvantsCalin Nicolescu, Essie Komla, Mangala Rao, et al.
Molecular Membrane Biology|November 28, 2006
HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodiesCarl R Alving, Zoltan Beck, Nicos Karasavva, et al.
Pageof 12